AlloSource®, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, received two patents from the United States Patent and Trademark Office for cartilage repair allografts.
The first, titled Perforated osteochondral allograft compositions, U.S. Patent Number 9,168,140, covers donated osteochondral tissue with a bone and cartilage layer perforated with small holes to allow for cellular migration and osteochondral repair. The second, titled Minced cartilage systems and methods, U.S. Patent Number 9,186,380, covers donated cartilage tissue processed to include small particles of cartilage containing living chondrocytes.
"The continued expansion of our intellectual property portfolio illustrates our dedication to growth and innovation," said Thomas Cycyota, AlloSource president and CEO. "AlloSource is passionate about developing new solutions for the medical community and will continue to be motivated by finding ways to honor the gift of human tissue donation by helping patients heal."
By focusing on quality, safety, service and a commitment to its mission, AlloSource has grown into one of the nation's largest tissue networks. The company's safety and tissue processing standards meet and exceed guidelines set forth by the United States Food and Drug Administration (FDA) and the American Association of Tissue Banks (AATB).
Solascure and U.S. Army Institute of Surgical Research collaborate for combat wound care